Shanmuga Hospital Share Price
44.00+1.00 (+2.33%)
-9.74% past 1 Year
Shanmuga Hospital is equipped with advanced healthcare technology. It addresses the community’s medical needs, serving patients from nearby regions. Accredited by the National Accreditation Board for Hospitals and Healthcare (NABH
Corporate filings & documents
Announcements
Newspaper publication of the Notice of the 06th Annual General Meeting
1 week agoNewspaper publication of the Notice of the 06th Annual General Meeting
1 week agoAnnual Report for financial year 2025-26.
1 week agoAnnual Report for financial year 2025-26.
1 week agoNotice of the 06th Annual General Meeting of Shanmuga Hospital Limited is scheduled to be held on Friday the 18th September 2026 at 02:30 PM. Through Video Conference or Other Audio Visual Means.
1 week agoNotice of the 06th Annual General Meeting of Shanmuga Hospital Limited is scheduled to be held on Friday the 18th September 2026 at 02:30 PM. Through Video Conference or Other Audio Visual Means.
1 week agoNewspaper Advertisement- 06th Annual General Meeting through Video Conferencing/Other Audio-Visual Means("VC/OAVM") facility
2 weeks agoNewspaper Advertisement- 06th Annual General Meeting through Video Conferencing/Other Audio-Visual Means("VC/OAVM") facility
2 weeks agoAlteration of the Memorandum of Association by insertion of new object clauses and alteration of the Articles of Association of the company subject to the approval of the Members of the Company.
3 weeks agoAlteration of the Memorandum of Association by insertion of new object clauses and alteration of the Articles of Association of the company subject to the approval of the Members of the Company.
3 weeks agoIncrease in the Authorised Share Capital of the Company from Rs. 14 00 00 000 (Rupees Fourteen Crores) to Rs. 25 00 00 000 (Rupees Twenty Five Crores) subject to approval of the Members of the Company.
3 weeks agoIncrease in the Authorised Share Capital of the Company from Rs. 14 00 00 000 (Rupees Fourteen Crores) to Rs. 25 00 00 000 (Rupees Twenty Five Crores) subject to approval of the Members of the Company.
3 weeks agoUnaudited Financial Results for the Quarter Ended June 30 2026
3 weeks agoUnaudited Financial Results for the Quarter Ended June 30 2026
3 weeks agoThe Board has approved the Unaudited Financial Results of the Company for the quarter ended June 30 2026 formulated the Employee Stock Option Plan 2026 and fixed the date of the 6th Annual General Meeting of the Company scheduled to be held on September 18 2026 at 02:30 P.M. through Video Conferencing (VC)/Other Audio-Visual Means (OAVM).
3 weeks agoThe Board has approved the Unaudited Financial Results of the Company for the quarter ended June 30 2026 formulated the Employee Stock Option Plan 2026 and fixed the date of the 6th Annual General Meeting of the Company scheduled to be held on September 18 2026 at 02:30 P.M. through Video Conferencing (VC)/Other Audio-Visual Means (OAVM).
3 weeks agoShanmuga Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2026 and to fix the date time and mode of the 6th Annual General Meeting and consider the adoption of the Shanmuga Hospital Limited Employee Stock Option Plan 2026 (ESOP 2026) subject to the necessary approvals.
1 month agoShanmuga Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter ended June 30 2026 and to fix the date time and mode of the 6th Annual General Meeting and consider the adoption of the Shanmuga Hospital Limited Employee Stock Option Plan 2026 (ESOP 2026) subject to the necessary approvals.
1 month agoThe Company has initiated the testing phase of its mobile application "Shanmuga 360".
1 month agoThe Company has initiated the testing phase of its mobile application "Shanmuga 360".
1 month agoCertificate pursuant to Regulation 74(5) SEBI (DP) Regulations 2018 for the period from 01.04.2026 to 30.06.2026
1 month agoCertificate pursuant to Regulation 74(5) SEBI (DP) Regulations 2018 for the period from 01.04.2026 to 30.06.2026
1 month agoExecution of Memorandum of Agreement with Central Government Health Scheme(CGHS) Ministry of Health & Family Welfare Government of India
1 month agoExecution of Memorandum of Agreement with Central Government Health Scheme(CGHS) Ministry of Health & Family Welfare Government of India
1 month agoClosure of Trading window
2 months agoClosure of Trading window
2 months agoResignation of Dr Mehak Jamwal AVP- Operations and Senior Management Personnel
3 months agoRe-Appointment of Internal Auditors for the Financial Year 2026-27
3 months agoRe-Appointment of Internal Auditors for the Financial Year 2026-27
3 months agoAudited Financial Results For The Half Year and Year Ended March 31 2026.
3 months agoApproval of Audited Financial Results for the Half-year and year ended 31st March 2026.
3 months agoApproval of Audited Financial Results for the Half-year and year ended 31st March 2026.
3 months agoShanmuga Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 inter alia to consider and approve The Audited Financial Results for the Quarter and year Ended March 31 2026.
4 months agoShanmuga Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 inter alia to consider and approve The Audited Financial Results for the Quarter and year Ended March 31 2026.
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Shanmuga Hospital Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85110TZ2020PLC033974</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>3.59</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: CS KANNAN ANJANA MARAGATHAM <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Mr KARTHICK S <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCertificate pursuant to Regulation 74(5) SEBI(DP) Regulations 2018 for the period from 01.01.2026 to 31.03.2026.
4 months agoCertificate pursuant to Regulation 74(5) SEBI(DP) Regulations 2018 for the period from 01.01.2026 to 31.03.2026.
4 months agoClosure of Trading Window
5 months agoClosure of Trading Window
5 months agoWe hereby inform you that Dr Vaishak M.L. Chief Operations Officer has tendered his resignation to pursue his growth opportunities outside the organization. Accordingly he shall be relieved from the services of the company with effect from the close of business hours on March 21 2026.
5 months agoWe hereby inform you that Dr Vaishak M.L. Chief Operations Officer has tendered his resignation to pursue his growth opportunities outside the organization. Accordingly he shall be relieved from the services of the company with effect from the close of business hours on March 21 2026.
5 months agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Appointment of Senior Management Personnel.
5 months agoIntimation under Regulation 30 of SEBI (LODR) Regulations 2015 - Appointment of Senior Management Personnel.
5 months agoIntimation regarding Commissioning and Operationalisation of Litho Evo Laser Machine
7 months agoCertificate pursuant to Regulation 74(5) of SEBI(DP)regulations 2018 for the period from 01.10.2025 to 31.12.2025
7 months agoDisclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
9 months agoInvestor Presentation under Regulation 30 read with Schedule III of SEBI(LODR) 2015
9 months agoStatement on Deviation or Variation for proceeds of public issue for the half year ended 30.09.2025
9 months agoUnaudited Financial Results For the Half Year Ended 30th September 2025 Together with the Limited review report.
9 months agoApproval of unaudited financial results for the half year ended 30th September 2025 together with the Limited Review Report.
9 months agoAnnual reports
Concalls & investor presentations
Nov 2025
ConcallPresentation
May 2025
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
51/24, Saradha College Road NULL NULL Salem Tamil Nadu PIN: 636007 Tel No: 0427 2706674 Fax No: NULL Email: [email protected] / [email protected] Internet: www.shanmugahospital.com
Registrars
30, Ramana Residency, 4th Cross, Sampige Road, Malleswaram, Bangalore 560003 30, Ramana Residency 4th Cross, Sampige Road Malleswaram PIN: Tel No: 91-080-23460815 to 818 Fax No: 91-080 23460819 Email: [email protected], [email protected] Internet: [email protected]
Management
Kannan Anjana Maragatham, Company Secretary & Compliance Officer
Dhandapani Priyadharshni, Non Executive Director
Karuppiah Saravanan, Non Executive Director
Gowri, Non Executive Independent Director
Bhoopathy Akilan, Non Executive Independent Director
Rajkumar Ashwin, Non Executive Independent Director
Panneerselvam Palaniappan Shanmugam, Managing Director
Prabu Sankar Panneerselvam, Executive Director & Chief Executive Officer
Jayalakshmi Panneerselvam, Executive Director
Details
BSE 544365
NSE NULL
ISIN INE0TD301017